Who Is the Customer in Pharma, Anyway?
One medicine, several decision-makers. Why the definition of a customer depends on the question.
HealthSynth Insights
A practical introduction to pharmaceutical customer analytics: who the customers are, what commercial teams need to understand, and why connecting the data is so challenging.
Featured series · Seven short articles
One fictional medicine. Many different decisions. Follow NovaMab from the question of who the customer is through fragmented reporting, connected datasets, and scenario analysis.
Start readingConceptual example · NovaMab is fictional
The reading roadmap
Each article stands on its own, but together they follow the business questions behind pharmaceutical customer analytics.
One medicine, several decision-makers. Why the definition of a customer depends on the question.
Why market context matters more than counting customers, calls, or prescriptions alone.
What traditional reporting gets right—and where manual reconciliation becomes difficult.
When teams use different definitions, even accurate reports can tell conflicting stories.
How shared identities, governed metrics, and modern data platforms enable deeper analysis.
Moving from historical reporting to explicit assumptions and controlled scenarios.
A bridge from customer analytics to the problem of developing and testing with synthetic data.
The series uses fictional examples to explain analytical ideas. It does not represent real patient, HCP, or market data.